Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 € ↑0,24 (3,28%)
2026-06-05
DEL PRIS
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership368,825 shares
Latest Disclosed Value $ 2,998,547
Citadel Advisors Llc ownership in KUR / Kura Oncology, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 368,825 shares of Kura Oncology, Inc. (DE:KUR) valued at $2,452,686 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 390,672 shares of Kura Oncology, Inc.. This represents a change in shares of -5.59% during the quarter. The current value of the position is $2,788,317 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (KUR) in the form of stock options. The firm currently holds call options representing 84,300 of underlying shares valued at $685,359 USD and put options representing 44,000 of underlying shares valued at $357,720 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:KUR / Kura Oncology, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KURA ONCOLOGY COM 50127T109 368,825 -21,847 -5.59 2,999 -26.14 0.0004
2026-02-17 2025-12-31 13F KURA ONCOLOGY COM 50127T109 390,672 -418,146 -51.70 4,059 -43.29 0.0006
2025-11-14 2025-09-30 13F KURA ONCOLOGY COM 50127T109 808,818 444,663 122.11 7,158 240.69 0.0011
2025-08-14 2025-06-30 13F KURA ONCOLOGY COM 50127T109 364,155 -30,086 -7.63 2,101 -19.22 0.0004
2025-05-15 2025-03-31 13F KURA ONCOLOGY COM 50127T109 394,241 -592,710 -60.05 2,602 -69.74 0.0005
2025-02-14 2024-12-31 13F KURA ONCOLOGY COM 50127T109 986,951 -202,044 -16.99 8,596 -63.00 0.0015
2024-11-14 2024-09-30 13F KURA ONCOLOGY COM 50127T109 1,188,995 175,852 17.36 23,233 11.37 0.0045
2024-08-14 2024-06-30 13F KURA ONCOLOGY COM 50127T109 1,013,143 994,696 5,392.18 20,861 5,207.89 0.0042
2024-05-15 2024-03-31 13F KURA ONCOLOGY COM 50127T109 18,447 -1,102,125 -98.35 393 -97.56 0.0001
2024-02-14 2023-12-31 13F KURA ONCOLOGY COM 50127T109 1,120,572 -351,720 -23.89 16,114 20.00 0.0032
2023-11-14 2023-09-30 13F KURA ONCOLOGY COM 50127T109 1,472,292 -444,323 -23.18 13,427 -33.78 0.0029
2023-08-14 2023-06-30 13F KURA ONCOLOGY COM 50127T109 1,916,615 -18,992 -0.98 20,278 -14.34 0.0042
2023-05-15 2023-03-31 13F KURA ONCOLOGY COM 50127T109 1,935,607 1,211,847 167.44 23,672 163.58 0.0052
2023-02-14 2022-12-31 13F KURA ONCOLOGY COM 50127T109 723,760 421,594 139.52 8,982 117.62 0.0021
2022-11-14 2022-09-30 13F KURA ONCOLOGY COM 50127T109 302,166 194,032 179.44 4,127 108.22 0.0009
2022-08-15 2022-06-30 13F KURA ONCOLOGY COM 50127T109 108,134 -45,599 -29.66 1,982 -19.82 0.0005
2022-05-16 2022-03-31 13F KURA ONCOLOGY COM 50127T109 153,733 -115,417 -42.88 2,472 -34.41 0.0005
2022-02-14 2021-12-31 13F KURA ONCOLOGY COM 50127T109 269,150 132,692 97.24 3,769 47.46 0.0008
2021-11-15 2021-09-30 13F KURA ONCOLOGY Cmn 50127T109 136,458 96,953 245.42 2,556 210.19 0.0005
2021-08-16 2021-06-30 13F KURA ONCOLOGY COM 50127T109 39,505 -1,395,712 -97.25 824 -97.97 0.0002
2021-05-21 2021-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 1,435,217 -1,632,396 -53.21 40,574 -59.50 0.0100
2021-05-17 2021-03-31 13F KURA ONCOLOGY COM 50127T109 1,435,217 -1,632,396 40,574 0.0100
2021-02-16 2020-12-31 13F KURA ONCOLOGY COM 50127T109 3,067,613 936,627 43.95 100,189 53.44 0.0261
2020-11-16 2020-09-30 13F KURA ONCOLOGY COM 50127T109 2,130,986 1,149,804 117.19 65,294 308.24 0.0185
2020-08-14 2020-06-30 13F KURA ONCOLOGY Cmn 50127T109 981,182 373,228 61.39 15,994 164.41 0.0057
2020-05-15 2020-03-31 13F KURA ONCOLOGY Cmn 50127T109 607,954 550,149 951.73 6,049 660.88 0.0027
2020-02-14 2019-12-31 13F KURA ONCOLOGY Cmn 50127T109 57,805 42,687 282.36 795 247.16 0.0003
2019-11-14 2019-09-30 13F KURA ONCOLOGY Cmn 50127T109 15,118 -286,568 -94.99 229 -96.14 0.0001
2019-08-14 2019-06-30 13F KURA ONCOLOGY Cmn 50127T109 301,686 301,686 5,940 0.0027
2019-05-15 2019-03-31 13F KURA ONCOLOGY Cmn 50127T109 0 -38,792 -100.00 0 -100.00
2019-02-14 2018-12-31 13F KURA ONCOLOGY Cmn 50127T109 38,792 10,961 39.38 544 11.70 0.0003
2018-11-13 2018-09-30 13F KURA ONCOLOGY Cmn 50127T109 27,831 2,123 8.26 487 4.06 0.0002
2018-08-14 2018-06-30 13F/A-1 KURA ONCOLOGY Cmn 50127T109 25,708 25,708 468 0.0002
2018-08-10 2018-06-30 13F KURA ONCOLOGY Cmn 50127T109 25,708 468 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F KURA ONCOLOGY COM Call 84,300 -43.91 685 -56.12 n/a n/a n/a
2026-02-17 2025-12-31 13F KURA ONCOLOGY COM Call 150,300 267.48 1,562 332.41 n/a n/a n/a
2025-11-14 2025-09-30 13F KURA ONCOLOGY COM Call 40,900 110.82 362 225.23 n/a n/a n/a
2025-08-14 2025-06-30 13F KURA ONCOLOGY COM Call 19,400 -42.26 112 -49.77 n/a n/a n/a
2025-05-15 2025-03-31 13F KURA ONCOLOGY COM Call 33,600 145.26 222 85.71 n/a n/a n/a
2025-02-14 2024-12-31 13F KURA ONCOLOGY COM Call 13,700 41.24 119 -37.04 n/a n/a n/a
2024-11-14 2024-09-30 13F KURA ONCOLOGY COM Call 9,700 -56.11 190 -58.46 n/a n/a n/a
2024-08-14 2024-06-30 13F KURA ONCOLOGY COM Call 22,100 125.51 455 117.70 n/a n/a n/a
2024-05-15 2024-03-31 13F KURA ONCOLOGY COM Call 9,800 19.51 209 78.63 n/a n/a n/a
2024-02-14 2023-12-31 13F KURA ONCOLOGY COM Call 8,200 -20.39 118 25.81 n/a n/a n/a
2023-11-14 2023-09-30 13F KURA ONCOLOGY COM Call 10,300 -33.97 94 -43.64 n/a n/a n/a
2023-08-14 2023-06-30 13F KURA ONCOLOGY COM Call 15,600 271.43 165 223.53 n/a n/a n/a
2023-05-15 2023-03-31 13F KURA ONCOLOGY COM Call 4,200 -36.36 51 -37.04 n/a n/a n/a
2023-02-14 2022-12-31 13F KURA ONCOLOGY COM Call 6,600 -90.58 82 -91.54 n/a n/a n/a
2022-11-14 2022-09-30 13F KURA ONCOLOGY COM Call 70,100 1.30 958 -24.45 n/a n/a n/a
2022-08-15 2022-06-30 13F KURA ONCOLOGY COM Call 69,200 11.79 1,268 27.44 n/a n/a n/a
2022-05-16 2022-03-31 13F KURA ONCOLOGY COM Call 61,900 27.37 995 46.32 n/a n/a n/a
2022-02-14 2021-12-31 13F KURA ONCOLOGY COM Call 48,600 61.46 680 20.57 n/a n/a n/a
2021-11-15 2021-09-30 13F KURA ONCOLOGY Cmn Call 30,100 119.71 564 97.20 n/a n/a n/a
2021-08-16 2021-06-30 13F KURA ONCOLOGY COM Call 13,700 -20.35 286 -41.15 n/a n/a n/a
2021-05-21 2021-03-31 13F/A KURA ONCOLOGY COM Call 17,200 -62.93 486 -67.92 n/a n/a n/a
2021-05-17 2021-03-31 13F KURA ONCOLOGY COM Call 17,200 486 n/a n/a n/a
2021-02-16 2020-12-31 13F KURA ONCOLOGY COM Call 46,400 168.21 1,515 185.85 n/a n/a n/a
2020-11-16 2020-09-30 13F KURA ONCOLOGY COM Call 17,300 -2.26 530 83.39 n/a n/a n/a
2020-08-14 2020-06-30 13F KURA ONCOLOGY Cmn Call 17,700 289 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F KURA ONCOLOGY COM Put 44,000 -49.60 358 -60.64 n/a n/a n/a
2026-02-17 2025-12-31 13F KURA ONCOLOGY COM Put 87,300 67.56 907 96.75 n/a n/a n/a
2025-11-14 2025-09-30 13F KURA ONCOLOGY COM Put 52,100 21.73 461 87.40 n/a n/a n/a
2025-08-14 2025-06-30 13F KURA ONCOLOGY COM Put 42,800 -33.64 247 -42.12 n/a n/a n/a
2025-05-15 2025-03-31 13F KURA ONCOLOGY COM Put 64,500 74.80 426 32.40 n/a n/a n/a
2025-02-14 2024-12-31 13F KURA ONCOLOGY COM Put 36,900 4,512.50 321 2,040.00 n/a n/a n/a
2024-11-14 2024-09-30 13F KURA ONCOLOGY COM Put 800 -94.63 16 -95.10 n/a n/a n/a
2024-08-14 2024-06-30 13F KURA ONCOLOGY COM Put 14,900 -62.94 307 -64.29 n/a n/a n/a
2024-05-15 2024-03-31 13F KURA ONCOLOGY COM Put 40,200 482.61 857 765.66 n/a n/a n/a
2024-02-14 2023-12-31 13F KURA ONCOLOGY COM Put 6,900 72.50 99 175.00 n/a n/a n/a
2023-11-14 2023-09-30 13F KURA ONCOLOGY COM Put 4,000 -75.00 36 -78.70 n/a n/a n/a
2023-08-14 2023-06-30 13F KURA ONCOLOGY COM Put 16,000 966.67 169 838.89 n/a n/a n/a
2023-05-15 2023-03-31 13F KURA ONCOLOGY COM Put 1,500 -92.46 18 -92.68 n/a n/a n/a
2023-02-14 2022-12-31 13F KURA ONCOLOGY COM Put 19,900 -46.22 247 -51.29 n/a n/a n/a
2022-11-14 2022-09-30 13F KURA ONCOLOGY COM Put 37,000 505 n/a n/a n/a
2022-05-16 2022-03-31 13F KURA ONCOLOGY COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F KURA ONCOLOGY COM Put 51,000 714 n/a n/a n/a
2022-03-11 2021-09-30 13F/A KURA ONCOLOGY COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F KURA ONCOLOGY COM Put 0 0 n/a n/a n/a
2021-08-16 2021-06-30 13F KURA ONCOLOGY COM Put 11,900 54.55 248 13.76 n/a n/a n/a
2021-05-21 2021-03-31 13F/A KURA ONCOLOGY COM Put 7,700 -68.31 218 -72.54 n/a n/a n/a
2021-05-17 2021-03-31 13F KURA ONCOLOGY COM Put 7,700 218 n/a n/a n/a
2021-02-16 2020-12-31 13F KURA ONCOLOGY COM Put 24,300 40.46 794 49.81 n/a n/a n/a
2020-11-16 2020-09-30 13F KURA ONCOLOGY COM Put 17,300 4.85 530 97.03 n/a n/a n/a
2020-08-14 2020-06-30 13F KURA ONCOLOGY Cmn Put 16,500 37.50 269 126.05 n/a n/a n/a
2020-05-15 2020-03-31 13F KURA ONCOLOGY Cmn Put 12,000 6.19 119 -23.23 n/a n/a n/a
2020-02-14 2019-12-31 13F KURA ONCOLOGY Cmn Put 11,300 155 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.